The IND is More Just an FDA Submission: It’s a Regulatory Positioning Strategy

For decades, FDA's Investigational New Drug (IND) application has been viewed primarily as a regulatory gateway. Submit the application, obtain FDA's approval to proceed, and begin clinical trials....